Clinical Trials Sponsored by Diako Ev. Diakonie-Krankenhaus gemeinnützige GmbH

Total 2 results

Diako Ev. Diakonie-Krankenhaus gemeinnützige GmbH

Completed

Risk-stratified Sequential Treatment of Post-transplant Lymphoproliferative Disease (PTLD) With Rituximab SC and Immunochemotherapy (PTLD-2)

Posttransplant Lymphoproliferative Disorder

Germany
University Hospital, Saarland
Charite University, Berlin, Germany; Goethe University; University Hospital Muenster and other collaborators

Terminated

Registry for Acute Pain Treatment

Pain, Postoperative | Regional Anesthesia

Germany

3

Subscribe